Activating mutations of the BRAF gene are the most common genetic alterations in papillary thyroid carcinomas (PTCs) and the T1799A transversion, resulting in BRAF V600E , appeared virtually unique in this cancer type. Here, we report on the identification in a classic PTC of a novel BRAF mutation, namely a 1795GTT insertion, resulting in BRAF V599Ins , and describe its biochemical and molecular characterization. Kinase assays carried out on BRAF V599Ins and BRAF V600E revealed a three-to five-fold increase in the enzymatic activity of both mutants with respect to BRAF , is a 'gain of function' mutation, characterized by a constitutive catalytic activation, which accounts for its causative role in the studied PTC. Keywords: papillary thyroid carcinoma; BRAF mutation; kinase assay; molecular dynamic simulation Constitutive activation of the RAF-MEK-ERK pathway is common to numerous cancers. Approximately 15% of human cancers harbour activating RAS mutations (Malumbres and Barbacid, 2003) . Similarly, increased RAS signalling might result from constitutive activation of receptor tyrosine kinases (RTKs) or deregulated activity of downstream transducers controlling RAS function, such as neurofibromin and SHP-2 (Cichowski and Jacks, 2001; Jerome et al., 2003; Bennasroune et al., 2004; Santoro et al., 2004; Tartaglia et al., 2004) . Very recently, large-scale genomic screens have also detected mutations of BRAF in 66% of malignant melanomas and at a lower frequency in colorectal and ovarian cancers (Davies et al., 2002) . At present time, other cancer types have been found to harbour BRAF mutations and over 30 missense mutations have been identified, the majority of which clusters in exons 11 and 15 and affects residues located within the kinase domain of the gene (Wan et al., 2004) . The T1799A transversion in exon 15, resulting in a V600E substitution, accounts for about 90% of all the oncogenic BRAF mutations (Wan et al., 2004) .
Numerous studies have consistently shown a high prevalence of BRAF mutation in papillary thyroid carcinomas (PTCs), ranging from 29 to 83% (Xing, 2005) . BRAF V600E resulted the virtually unique mutation in more than 500 PTC analysed so far with few exceptions (Ciampi et al., 2005; Oler et al., 2005; Trovisco et al., 2005a, b) .
Crystal structures of wild type and oncogenic BRAF V600E kinase domains have been recently solved, aiding the understanding of the mechanism involved in BRAF activation (Wan et al., 2004) . In particular, the amino-and carboxy-terminal lobes (respectively, N-lobe and C-lobe) of BRAF catalytic domain constitute a cleft that catalyses the enzymatic activity. In basal condition, molecular interactions between two regions of BRAF protein, namely the activation loop (A-loop) in the Clobe and the glycine-rich phosphate-binding-loop (Ploop) in the N-lobe, stabilize the inactive conformation of the kinase. Upon substrate recognition, the activation loop undergoes a conformational change that set free the catalytic cleft and allows the enzyme to achieve a full active state (Dibb et al., 2004) .
BRAF oncogenic mutations are mostly clustered to the conserved A-and P-loops and destabilize the inactive conformation of BRAF, thereby promoting a constitutive activity of the enzyme.
Aim of the present study was to functionally characterize the novel BRAF V599Ins mutation recently detected in a classic PTC arrived to our observation (Carta et al., 2006) (Figure 1) (Figure 2a ). Therefore, we sought to determine the effects exerted by the V599Ins mutation on BRAF-mediated stimulation of the mitogen-activated protein kinase (MAPK) cascade. We studied the MAPK cascade in HEK293 cells transiently transfected with the various BRAF constructs. A representative experiment is reported in Figure 2b . Phosphorylation of MEK, MAPK and RSK was virtually undetectable in vector-transfected cells. Moreover, the MAPK cascade was significantly more active in cells expressing BRAF V600E or BRAF V599Ins than in cells expressing BRAF WT . In the last ones, only modest levels of phosphoMAPK were detectable.
To determine the molecular mechanism involved in BRAF destabilization upon gain of the V599Ins mutation, we performed three molecular dynamic simulations on virtually generated structural models of BRAF WT , BRAF V600E and BRAF
V599Ins
. The van der Waals and electrostatic components of the interaction energy between the activation loop and the catalytic site were calculated along the simulations. In particular, the catalytic site was defined by residues belonging to 
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S Moretti et al the P-loop (residues 462-471) and C-helix (residues 492-506). The A-loop comprised residues 593-622. Figure 3a -b shows the calculated van der Waals and electrostatic components of the interaction energy. During the simulations, the van der Waals energy of BRAF V599Ins started higher than the other mutant and the wild type (Figure 3a) . This was because steric bumps were still present into the model due to the insertion of a residue more in BRAF
V599Ins
. However, a similar behaviour was also observed for BRAF V600E compared to BRAF WT . At the end of the simulations, the van der Waals energy reached a similar minimum in both mutants of BRAF being, respectively, 5 and 4 kcal/mol the difference over the minimum conformation of BRAF WT . The electrostatic interactions between the activation loop and the catalytic site showed marked differences along the simulations depending on the system considered ( Figure 3b ). The inactive conformation of BRAF WT was strongly stabilized by a very low electrostatic energy of interaction for all the duration of the simulation, but it was not in BRAF V600E and BRAF
. During the last ns, the average of the electrostatic energy in BRAF WT was À79.29 kcal/mol versus À14.05 kcal/mol in BRAF V600E and À4.50 kcal/ mol in BRAF V599Ins (Table 1) . Thus, the mutant proteins exhibited much higher repulsive electrostatic forces inside the catalytic core compared to BRAF WT . In order to gain further insight into the regions of BRAF V600E and BRAF V599Ins where the electrostatic forces acted, we plotted the vectors of the forces acting into the enzyme during the last ns of the simulations (Figure 3c-e) . The plots revealed that the vectors were clustered around specific regions of the mutant enzymes (Figure 3d and e) . In contrast, vectors of the electrostatic forces acting in BRAF WT were spread out on the Cartesian planes ( Figure 3c ). We were able to identify those structural regions by plotting the atomic coordinates of the enzymes at the last ns onto the vector graphs. In particular, these areas covered the centre of mass of the DFG motif (Asp594-Phe595-Gly596) of the activation loop (red dot in Figure 3c -e). Furthermore, the vectors of the electrostatic forces affected slightly different portions of the catalytic site in BRAF V599Ins and BRAF V600E (Figure 3f-g ). These data indicate that the identified repulsive electrostatic forces act on the activation loop and move from inward to outward of the mutant enzymes. In addition, they pinpoint similar but not identical active conformations reached by both BRAF mutants.
In order to evaluate the transforming potential of the BRAF V599Ins mutation, focus transformation assays were performed. As shown in Figure 4a , plates of NIH-3T3 cells transfected with BRAF V600E or BRAF V599Ins were characterized by the formation of a significant number of transformation foci. On the contrary, in the same conditions, cells transfected with the WT BRAF construct and the vector, or parental NIH-3T3, formed a negligible number of transformation foci.
In accordance with the transformation potential of BRAF V599Ins , a clonal cell line expressing the mutation (data not shown), isolated from a transformation focus, showed a dramatic change in cell morphology ( Figure 4b ) and a high proliferation rate in low serum (CS 1%) (Figure 4c ).
In the present study, we functionally characterized a novel mutation of BRAF generated by an in-frame insertion of three bases at position 1795, resulting in the insertion of a Valine residue at codon 599 (BRAF V599Ins ). To our knowledge, it has been reported for the first time either in PTCs or in non-thyroidal tumours. Its rarity is related to the requirement of a nucleotide triplet insertion exactly between two codons, an event statistically far less probable than a simple base substitution. Of note, the patient harbouring the BRAF V599Ins mutation was affected by a T1N0M0 classic papillary carcinoma, with no relapse at 3 years from initial treatment, phenotypically not different from other PTC harbouring the common BRAF V600E mutation (Puxeddu et al., 2004) . by Dr Jeffrey Knauf, University of Cincinnati), using the QuickChange XL mutagenesis kit (Stratagene) according to manufacturer's instructions (forward primer GGTGATTTTGGTCTAGCTGTTACAGTGAAATCTC GATGG, reverse primer CCATCGAGATTTCACTGTAACAG CTAGACCAAAATCACC). Correct insertion of the mutation was confirmed by DNA sequence analysis. Transient transfections were carried out with the lipofectamine reagent according to manufacturer's instructions (GIBCO). Cells were seeded at a density of 1.5 Â 10 6 /dish the day before transfection and transfected with 2 mg of DNA. For the BRAF kinase assay (Melillo et al., 2005) , transiently transfected HEK293 cells were kept for 12 h in serum-deprived medium and harvested. BRAF kinase was immunoprecipitated with the anti-myc tag antibody and resuspended in a kinase buffer containing 25 mM sodium pyrophosphate, 10 mCi 32 P ATP and 1 mg of recombinant GST-MEK (Upstate Biotechnology Inc., Lake Placid, NY, USA). After 30 min incubation at 41C, reactions were stopped by adding 2 Â Laemmli buffer. Proteins were then subjected to 12% SDS gel electrophoresis. The radioactive signal was analyzed at the Phosphorimager. Data are representative of at least three different experiments. Immunoblots of aliquots of the obtained immunocomplexes with anti-BRAF and anti-MEK antibodies were performed as loading controls. (b) Effects exerted by BRAF mutants on BRAF-mediated stimulation of the mitogen-activated protein kinase (MAPK) cascade. For immunoblotting experiments, transiently transfected HEK 293 cells were harvested after 48 h from the transfection and Western blots were performed on protein extracts as previously described (Melillo et al., 2005) . Anti-phospho p44/42 MAPK (#9102), anti-p44/42 MAPK (#9101), anti-phospho p90RSK (90 kDa ribosomal S6 kinase) (#9344), anti-p90RSK (#9347), anti-phospho MEK1/2 (MAP kinases 1 and 2) (#9121), and anti-MEK1/2 (#9122) were purchased from Cell Signaling (Beverly, MA, USA). Anti-BRAF antibody (sc-9002) and anti-myc tag (9E10) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal anti-a-tubulin was from Sigma Chemical Co. Secondary antibodies coupled to horseradish peroxidase were from Santa Cruz Biotechnology. Data are representative of at least three different experiments.
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In order to gain insight into the functional properties of BRAF V599Ins mutant, we investigated the effect of the Valine insertion on the catalytic activation of BRAF, compared with BRAF V600E and BRAF WT , using both biochemical assays and molecular dynamic simulations. Moreover, its transformation potential was analysed performing focus assays.
Kinase assays, conducted using a GST-MEK protein as substrate, revealed a three-to five-fold increase in the enzymatic activity of both the BRAF V599Ins and the Figure 3 Results of the molecular dynamic simulations. The atomic coordinates of BRAF WT and BRAF V600E were retrieved from the protein data bank (pdb codes: 1uwh, 1uwj) and the inhibitor BAY43-9006 was removed while keeping the crystal water (Barman et al., 2000) . Hydrogen atoms were added using Insight-II (Accelrys Insight-II, San Diego, CA, USA). The region encompassing residues 601-612 (12 residues), not solved into the crystal structures, was modelled using the loop building routine of Modeller (Fiser and Sali, 2003) . The same strategy was used to generate the insertion of Valine between positions 598-599. The resulting loop regions of each model were energy refined using 1000 steps of conjugate gradients minimization in order to remove bad contacts. At this purpose, Charmm22 force field was used (Brooks et al., 1983) . Each model was solvated using Solvate v.1.0 with its default settings (Grubmu¨ller, 1996) . Sodium and chlorine atoms were placed to counter-balance the net charges of the enzyme. All models were energy minimized for 5000 steps using the method of conjugate gradients in NAMD v.2.5 (Kale´et al., 1999) . During the minimization protocol, the backbone of the enzyme was kept fixed. The water shell and all counter-ions were then equilibrated for 500 ps at 300 K. The temperature of 300 K was reached starting from 0 K in the first 10 ps of the simulation. The final coordinates were submitted to a simulation of 4 ns removing the constrains on the backbone. Spherical harmonic boundary conditions (SBC) were applied in the simulations with a force constant of 0.1 kcal/mol Å 2 and an exponent of 2 set to a radius of 45 Å from the centre of mass of the solute. A time step of 2 fs was used and the ShakeH algorithm was applied. Molecular dynamic calculations were performed using NAMD v.2.5 and Charmm22 force field. Top panel. Plots of the van der Waals (a) and electrostatic (b) components of the interaction energy during the time of simulations of BRAF WT (red line), BRAF V600E (black line) and BRAF V599Ins (yellow line). Middle panel. Plots of the vectorial components of the electrostatic forces for BRAF WT (c), BRAF V600E (d) and BRAF V599Ins (e). The red dot indicates the region where the centre of mass of the DFG motif in the activation loop (Asp594-Phe595-Gly596) is located. Bottom panel. Conformations of BRAF V599Ins (f) and BRAF V600E (g) at the end of molecular dynamic simulations. The area of influence of the vectors of the electrostatic forces is highlighted in green over a ribbon representation of the mutant structures. The DFG motif, falling in this area, is shown in yellow CPK style. The activation loop, P-loop and C-helix are displayed according to the secondary structure and colour coded, respectively, in orange, white and cyan. The average vector of the electrostatic forces during the last ns of the simulation is represented as a red dot connecting the centre of the coordinate system in the core of the enzyme (white dot). revealed the expected destabilization of the inactive conformation of the enzyme in the two mutants.
The inspection of the energy plots showed that repulsive electrostatic interactions play a major role in the destabilization of the inactive conformation of the enzyme in both BRAF V600E and BRAF V599Ins (Figure 3a-b) . Conversely, the contribution of the van der Waals interactions to the destabilization of the inactive conformation of BRAF was negligible.
Since the electrostatic energy of interaction between the activation loop and the catalytic site is the driving force that destabilizes the inactive conformation of BRAF V600E and BRAF
V599Ins
, we investigated the electrostatic forces acting on the activation loop during the last Figure 3c -e shows that the x, y and z components of the forces are clustered around a specific region in the mutant enzymes whilst are spread out on the planes in the case of BRAF WT . In the wild type, indeed, the electrostatic forces acting on the activation loop are in equilibrium and the net result is a stabilization of the inactive conformation of the kinase.
The region where vectors clustered during the last ns in BRAF V600E and BRAF
, comprised the DFG motif (Asp594-Phe595-Gly596) in the activation loop (Figure 3f-g ). The net result is a repulsive electrostatic force moving from inward to outward of the enzyme that pushes away the DFG motif which, in turn, triggers the adoption of the active conformation by the activation loop.
Finally, focus transformation assays clearly demonstrated also an in vitro transforming activity of both BRAF mutants, strengthening the notions coming from the biochemical and molecular findings.
In conclusion, this study demonstrates that BRAF-
, as BRAF
V600E
, is a 'gain of function mutation', which is characterized by a constitutive catalytic activation and accounts for its causative role in the studied PTC. A computational analysis of the molecular basis responsible for the activation of BRAF V599Ins and BRAF
, pinpoints that high electrostatic energies are responsible for the destabilization of the inactive conformation of the two mutant enzymes in a very similar manner.
